Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Diffusion network model analysis of multimodal neuroimaging reveals differential patterns of brain disease propagation in four subgroups of ALS patients.

Brain imaging and behavior·2026
Same author

The Tuesday lessons of ALS.

The Lancet. Neurology·2026
Same author

Detour ahead: possible causes of corticospinal tract truncation in upper motor neuron-predominant amyotrophic lateral sclerosis.

Brain communications·2025
Same author

Shared burden of ultra-rare genetic variants across a spectrum of motor neuron diseases.

Translational neurodegeneration·2025
Same author

Predicting Amyotrophic Lateral Sclerosis Mortality With Machine Learning in Diverse Patient Databases.

Muscle & nerve·2025
Same author

Predictive Analysis of Amyotrophic Lateral Sclerosis Progression and Mortality in a Clinic Cohort From Singapore.

Muscle & nerve·2025

相关实验视频

Updated: Jul 9, 2025

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
12:35

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Published on: March 17, 2012

28.1K

通过机器学习预测肌缩侧面硬化症 (ALS) 的进展.

Muzammil Arif Din Abdul Jabbar1,2, Ling Guo3, Sonakshi Nag3

  • 1Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.

Amyotrophic lateral sclerosis & frontotemporal degeneration
|December 5, 2023
PubMed
概括

机器学习模型可以使用患者数据预测肌缩侧面硬化症 (ALS) 的进展. 较短的观察期和已识别的预测因素可能会简化临床试验并揭示新的治疗点.

关键词:
这就是ALS.机器学习是机器学习.运动神经元疾病 运动神经元疾病

更多相关视频

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

19.7K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

相关实验视频

Last Updated: Jul 9, 2025

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
12:35

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Published on: March 17, 2012

28.1K
A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

19.7K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

科学领域:

  • 神经学 神经学
  • 生物统计学 生物统计学
  • 计算生物学 计算生物学

背景情况:

  • 肌缩侧面硬化症 (ALS) 是一种进展性神经退行性疾病.
  • 预测ALS进展对于临床试验设计和患者管理至关重要.
  • 当前的预测方法可能无法充分利用机器学习的潜力.

研究的目的:

  • 开发和评估用于预测ALS进展的机器学习 (ML) 模型.
  • 评估不同观察和预测窗口长度对模型性能的影响.
  • 为了确定ALS疾病进展的关键预测因素.

主要方法:

  • 利用了PRO-ACT数据库中的5030名患者的人口,临床和实验室数据.
  • 模拟ALS进展 (快速与非快速) 使用极端梯度增强 (XGBoost) 和贝叶斯长短期记忆 (BLSTM).
  • 使用AUROC评估模型性能,并在不同观察长度 (一次访问到12个月) 中进行比较.

主要成果:

  • ML模型实现了0.570-0.748的AUROC,与临床医生的评估相当.
  • 模型性能在观察长度上是一致的,但在更长的预测窗口中得到了改善.
  • 确定了21种进展预测因素,包括疾病发病,ALSFRS-R,强迫生命能力,,化物和白.
  • 对于某些样本,BLSTM模型对预测的信心更高.
  • 通过模型对患者进行查,可以假设将临床试验大小减少18.3%.

结论:

  • 机器学习模型为预测ALS进展提供了一种可行的方法.
  • 临床试验的观察期可能会缩短到一次访问,从而减少试验规模.
  • 已识别的预测因子可以作为新的生物标志物和ALS的治疗点.
  • BLSTM信心水平提高了临床决策预测的可靠性.